期刊文献+

HPV16假病毒制作方法优化 被引量:2

Optimize the construction method of HPV16 pseudovirus
原文传递
导出
摘要 目的为了优化HPV16假病毒制作方法。方法本实验用L1/L2结构蛋白质粒和p CMV-Gluc质粒,从融合试剂,结构质粒与报告质粒比例,细胞接种密度和收获时间等4个方面优化了HPV16假病毒的制作过程,ELISA验证不同抗体水平下假病毒检出效果。结果最优条件分别为E498b,结构质粒与报告质粒2:1,293FT细胞接种密度50%,收获时间48h或72h能够达到最佳包装效率。优化后的假病毒TCID50能够达到105.55,血清ELISA滴度分别为1:2000;1:8000;1:16000,中和实验ID50分别为90,270和810,具有很好的区分度。结论证明该优化方法现实可行,为HPV假病毒生产和中和抗体检测提供了一定的参考意义,为后续病毒试验提供了依据。 Objective: To optimize the construction method of HPV16 pseudovirus, Methods: In this experiment, we used L1 / L2 structural protein plasmids and pCMV-Gluc plasmids to optimize the construction method of HPV16 pseudovirus from four aspects as fusion reagents, the ratio of structural plasmids and reporter plasmids, density of cell seeding and harvest time. We used ELISA to verify the detection effect of pseudovirus under different antibody levels. Results: Optimal conditions were E498b, structural plasmid and reporter plasmid 2: 1, density of 293FT cell seeding was 50%, the harvest time was 48h or 72h, which could achieve the best efficiency. TCID50 of optimized pseudovirus reached 105.55. The serum ELISA titer were 1: 2000; 1:8000 and 1:16 000 respectively, and neutralization experiment ID50 were 90, 270 and 810 respectively, with good discrimination. Conclusion: This optimization method proves feasible, and it provides some referenced value for the production of HPV16 pseudovirus and the detection of neutralizing antibody, and provides basis for the virus test.
出处 《中国优生与遗传杂志》 2016年第6期19-21,46,F0003,共5页 Chinese Journal of Birth Health & Heredity
基金 湖北省卫生厅(项目编号2012Z-Y02) 湖北省卫计委一般面上项目(项目编号WJ2015MB084) 国家自然科学基金(项目编号81302273)
关键词 人乳头瘤病毒(HPV16) 假病毒 优化 HPV16 Pseudovirus Optimization
  • 相关文献

参考文献13

  • 1Baker T, Newcomb W, Olson N, et al. Structures of bovine and human papillomaviruses. Analysis by cryoelectron microscopy and three-dimensional image reconstruction[J].Biophysical Journal, 1991,60:1445-1456.
  • 2Doorbar J, Quint W, Banks L, et al. The biology and life-cycle of human papillomaviruses [J].Vaccine, 2012, 30 :F55-F70.
  • 3HPV and cervical cancer in the 2007 report[J].Vaccine, 2007, 25 Suppl 3 :C1-230.
  • 4Kirnbauer R, Taub J, Greenstone H, et al. Efficient self-assembly of human papillomavirus type 16 L1 and L1-L2 into virus-like particles[J].J Virol, 1993,67 (12) :6929-6936.
  • 5Zhou J, Sun XY, Stenzel DJ, et al. Expression of vaccinia recombinant HPV 16 L1 and L20RF proteins in epithelial cells is sufficient for assembly of HPV virion-like particles[J].Virology, 1991, 185 (1) :251-257.
  • 6Buck CB, Pastrana DV, Lowy DR, et al. Efficient intracellular assembly of papillomaviral vectors[J].J Virol, 2004, 78 (2) : 751-757.
  • 7BedeU MA, Hudson JB, Golub TR, et al. Amplification of human papillomavirus genomes in vitro is dependent on epithelial differentiation[J]. J Viro 1,1991,65 (5) :2254-2260.
  • 8Harper DM, Franco EL, Wheeler C, et al. Efficacy of a bivalent L1 virus-like particle vaccine in prevention of infection with human papillomavirus types 16 and 18 in young women :a randomised controlled trial [J].Lancet, 2004, 364 (9447) : 1757-1765.
  • 9Villa LL, Ault KA, Giuliano AR, et al. Immunologic responsesfollowing administration of a vaccine targeting human papillomavirus Types 6, 11,16, and 18[J].Vaccine, 2006,24 (27-28) :5571-5583.
  • 10Yun W, Zheng F, James Lee L. Coaxial electrohydrodynamic spraying of plasmid DNA/polyethylenimine (PEI) polyplexes for enhanced monviral gene delivery[J].Biotechnology and Bioengineering, 2010,4 (105) :834-841.

二级参考文献22

  • 1许巍,富建华,薛辛东.高氧致新生鼠慢性肺疾病HoxB5 SPC AQP5表达及其意义[J].中国当代儿科杂志,2009,11(1):51-55. 被引量:5
  • 2李经忠,王青青,余海.新型非病毒载体聚乙烯亚胺介导基因转染参数的研究[J].中国生物医学工程学报,2006,25(4):481-487. 被引量:16
  • 3卢五迅,程通,李少伟,潘晖榕,沈文通,陈毅歆,张涛,郑舟,张军,夏宁邵.人乳头瘤病毒16型假病毒中和实验的建立和初步应用[J].生物工程学报,2006,22(6):990-995. 被引量:13
  • 4Finnen R L, Erickson K D, Chen X S, et al. Interactions between papillomavirus L1 and L2 capsid proteins[J]. J Virol, 2003,77(8) :4818-4826.
  • 5Schiller J T, Davies P. Delivering on the promise: HPV vaccines and cervical cancer[J]. Nat Rev Microbiol,2004, 2(4):343--347.
  • 6Koutsky L A,Galloway D A, Holmes K K. Epidemiology of genital human papillomavirus infection[J]. Epidemiol Rev, 1988,10 : 122-- 163.
  • 7Bedell M A,Hudson J B,Golub T R,et al. Amplification of human papillomavirus genomes in vitro is dependent on epithelial differentiation[J]. J Virol, 1991,65 (5) : 2254 -- 2260.
  • 8Pastrana D V, Buck C B, Pang Y Y, et al. Reactivity of human sera in a sensitive, high-throughput pseudovirus- based papillomavirus neutralization assay for HPV16 and HPV18[J]. Virol,2004,321 (2):205--216.
  • 9Pyeon D, Lambert P F, Ahlquist P. Production of infectious human papillomavirus independently of viral replication and epithelial cell differentiation[J]. Proc Natl Acad Sci USA,2005,102(26) :9311--9316.
  • 10Buck C B, Thompson C D, Pang Y Y, et al. Maturation of papillomavirus eapsids [J ]. J Virol, 2005,79 (5) : 2839 - 2846.

共引文献8

同被引文献19

引证文献2

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部